James Levy is an international investment advisor with over twenty-five years of experience both as a Senior Vice President in Merrill Lynch International Private Bank and the founder of Clearwater Private Investment, a boutique investment consulting firm. James is also Senior Advisor for Business Development of the Luxembourg-based Synthesis Sicav-Sif, the investment managers of Europe’s first regulated Peer-to-Peer Lending Fund, as well as a speaker and writer on Alternative Finance and Market-based Lending. James is a strong advocate for the urgent need for Investment Advisors to embrace alternative finance and market lending for the benefit of their clients, who now face the daunting challenge of saving for retirement in a near-zero interest rate world.
Alex is an equity research analyst at Granite House Capital Management, a value oriented long/short hedge fund based in Boston. In May 2013, Alex was the feature of a Forbes Magazine article titled, "Meet One Of The Youngest And Brightest Hedge Fund Analysts That Isn't On Wall Street." He started investing in the stock market at age 10 and payed for college by working as an analyst for a Minneapolis based hedge fund. He focuses on the investing methods of great investors such as Warren Buffett. Alex looks to differentiate himself in the industry through persistent hard work and continuous learning. He is the youngest ever admitted member of the SumZero buyside network and was one of 14 buyside analysts in nation to be named to the 2012 SumZero Buyside Analyst Honors which was published in the Wall Street Journal as part of the 'Best on the Street' column and CNBC. Over 8,000 analysts were considered and he had the second highest return on the list. He was featured in the biography of investor Warren Buffett in a book called "Of Permanent Value: The Story Of Warren Buffett,". He maintains a blog called "Alex Bossert's Thoughts On Value Investing" with over 550 subscribers and over 300,000 site views. His work has been syndicated on Yahoo Finance, Google Finance, SeekingAlpha, and GuruFocus.
Linkedin Profile: http://www.linkedin.com/in/alexbossert
Currently Vice President of Business Development dedicated to the discovery and creation of shareholder value for Life Science companies.
--Extensive Scientific Research experience in Pharmaceutical and Medical Device Companies AMGEN, ALLERGAN
--Experience as Technical Liaison/Advisor for prominent financial institutions focused on Healthcare and Biotech investments
Prior experience includes:
AMGEN: (Research Scientist ) Drug Product Process Development, Drug Engineering, FDA technology- liaison, Product Characterization, Commercial Manufacturing Support, Commercial Drug Development , Drug Formulation and Pre-commercial Drug Product Tech Transfer.
ALLERGAN: (Research Scientist) Project design and management of proprietary materials and data for medical device and medical aesthetic products. Scientific research team lead of collagen and capsular-contracture studies for devices. Biomaterial optimization applying advanced histology, cell culture and immunohistochemistry.
OPUS Point Partners/OPN Capital Markets/ National Securities: Scientific Advisor and technology liaison. Worked alongside lead market strategist and lead biotech analyst at National Securities for The Biotech Group. Lead the due diligence process for the Managing Director at OPN Capital Markets, reviewing product mechanisms,intellectual property and overall technology/concept viability.
Businessman (61) Engineering degree and MBA, 35 years as stock investor and 4 years as trader.
Spending a fair amount of time reading and analyzing sectors where I feel opportunity for investment goals and skills, sectors as Energy and Technology stocks in a mix of dividend stocks (70%) and growth increasingly in options (20%), and a final 10% for speculation.
Living part time between Barcelona, Spain, and a few months a year in Rio Grande Valley in South of Texas and a motor-home in Europe.